Two of the most important goals in the treatment of patients with inflammatory bowel disease are to improve patient quality…
Browsing: Hot headlines in GI
IRVINE, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic…
The US Food and Drug Administration (FDA) has granted Fast Track designation for Agenus’ combination therapy for the treatment of colorectal cancer.…
Rapid blood test sensitive to advanced adenomas could improve patient prognosis and ultimately reduce mortality ORLANDO, Fla.–(BUSINESS WIRE)– Dxcover Limited, a…
Meridian Bioscience has announced FDA 510(k) clearance of its Curian Shiga Toxin assay intended for detection and differentiation of Shiga…
Irritable bowel syndrome impacts between 25 and 45 million people in the U.S., causing symptoms including severe abdominal pain and altered bowel…
Gastroenterologist income is up 11 percent in the last year, reaching $501,000 annually, according to Medscape’s 2023 “Physician Compensation Report” published April…
Colorectal cancer (CRC) remains the second most common cause of cancer-related death in the United States. Although the past several…
Key takeaways: Multimodal prehabilitation reduced the incidence of severe postoperative complications and enhanced functional recovery among patients who underwent elective resection of…
Precision diagnostics company Oncocyte on Friday announced the publication of results from the randomized phase II AtezoTRIBE clinical trial for…